Topical Anticancer Agents Flashcards
What are the indications for DCP?
Wart
Alopecia areata
Melanoma in transit
What are the contraindications to DCP?
Pregnancy
Children <10 years
Atopic dermatitis
What is the process for administering DCP?
Priming: 3 drops 2% DCP in Finn chamber to upper inner arm, leave on 48 hours and review ?sensitisation
Wart
Treatment: 0.1% DCP + 15% salicylic acid in white soft paraffin
Apply 3 times a week (with gloves & toothpick)
Wash off in AM, pare/pumice
Alopecia areata
0.001% DCP in aqueous cream
—> 0.01%
——> 0.1%
Until eczematous reaction
Wash off AM
Follow up 2 weeks
Treatment duration 1-3 months
What are the adverse effects of DCP?
Common: contact dermatitis, lymphadenopathy, blistering, skin infection
Uncommon: urticaria, EM, vitiligo/leukoderma, PIH
How do you manage generalised dermatitis/urticaria due to DCP?
Cease DCP
Empathise
Explain pathogenesis
Explore dosing/application technique
Cetirizine +- phenergan
Prednisone 0.5-1mg/kg/day tapered over 2-3 weeks
What are the indications for cantharadin?
Wart
Molluscum contagiosum
What are the contraindications to cantharadin?
Hypersensitivity
Lesion on mucous membranes
Mosaic warts
Circulatory disease eg diabetes, PVD
What are the adverse effects of cantharadin?
Pain, ICD, PIH
Annular ring wart
Cellulitis/lymphangitis
Rare: kidney or liver injury, GI haemorrhage, coagulopathy, seizure, arrhythmia, shock
What formulations does cantharadin come in?
Cantharadin (plain) 0.7%
Cantharadin plus 1%
+ podophyllin 5%
+ salicylic acid 30%
How is cantharadin applied for the treatment of warts?
Pare/shave wart
Apply cantharadin with toothpick
Apply non porous adhesive tape and leave on for 4-6hours
Remove tape and wash site
Advise patient/parent that blister forms 24-48 hours and dries up/falls off after 1 week
80% cute rate
Retreatment 1-3 weeks
How does the use of cantharadin differ between warts and molluscum contagiosum?
No occlusion
Can be combined with aldara
What is the MOA of imiquimod?
Potent TLR 7 & 8 agonist
What are the contraindications to the topical anticancer agents?
Hypersensitivity
Pregnancy/lactation
Dihydro-pyrimidine dehydrogenase deficiency (efudix)
Marked hyperkeratosis
Ulcerated/broken skin
Large lesion/treatment area
Perioroficial site
Infiltrative/recurrent/high risk lesion
Photosensitivity
Immunosuppression
Decreased haematological reserve (imiquimod)
Autoimmune disease (imiquimod)
Unreliable patient
What is the MOA of efudix?
Topical chemotherapeutic agent that selectively effects dividing cells
Acts as an antimetabolite —> blocks DNA synthesis —> prevents cell proliferation —> cell death
What is the MOA of topical diclofenac?
Unknown
?inhibits COX2 pathway leading to reduced PGE2 synthesis